We are happy to announce that we are LegitScript Certified.
Patient Resources
Get Healthy!
Is Tamoxifen Alone a Viable Option for Women with Low-Risk DCIS Breast Cancer?
- December 16, 2025
- HealthDayTV HealthDay Reporter
In a new study, women with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence rates than researchers expected. But they say the incidence of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone may be an option in “carefully selected patients.”
